Response Genetics Inc. announced the addition of Stephanie H. Astrow, Ph.D., as the company's Vice President for Research and Development. In her role, Dr. Astrow will be responsible for leading the company's research and development programs, as well as identifying and incorporating new technologies into the services that the company provides to the medical community. Most recently, Dr. Astrow was Scientific Director for Oncology at Quest Diagnostics. At Quest, she played a key role in expanding business by introducing new assays and services, as well as coordinating development strategy for companion diagnostics with key pharmaceutical companies.